BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
MINNEAPOLIS, May 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities Health Care Conference on Tuesday, May 14, 2024, at 2:20 p.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at
明尼阿波利斯2024年5月8日 /PRNewswire/ — Bio-Techne Corporation（納斯達克股票代碼：TECH）今天宣佈，總裁兼首席執行官金·凱爾德曼將於太平洋夏令時間2024年5月14日星期二下午2點20分出席美銀證券醫療保健會議。可以通過Bio-Techne投資者關係網站的投資者關係網站的投資者關係日曆頁面觀看該演示的網絡直播
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit or follow the Company on social media at Facebook, LinkedIn, Twitter or YouTube.
Bio-Techne
Bio-Techne Corporation（納斯達克股票代碼：TECH）是一家全球生命科學公司，爲研究和臨床診斷界提供創新工具和生物活性試劑。Bio-Techne 產品有助於對生物過程以及特定疾病的性質和進展進行科學研究。它們有助於藥物發現工作，爲準確的臨床測試和診斷提供手段。Bio-Techne的產品組合中有數千種產品，在2023財年創造了超過11億美元的淨銷售額，在全球擁有約3,100名員工。有關Bio-Techne及其品牌的更多信息，請在臉書、領英、推特或YouTube的社交媒體上訪問或關注該公司。
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
[email protected]
612-656-4416
關於生物技術公司（納斯達克股票代碼：TECH）
聯繫人：投資者關係與企業發展副總裁戴維·克萊爾
[電子郵件保護]
612-656-4416
SOURCE Bio-Techne Corporation
來源 Bio-Techne 公司
譯文內容由第三人軟體翻譯。